Articles with "gvhd" as a keyword



Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.

Sign Up to like & get
recommendations!
Published in 2024 at "JAMA dermatology"

DOI: 10.1001/jamadermatol.2023.6277

Abstract: Importance Chronic graft-vs-host disease (GVHD) is associated with impaired quality of life and symptom burden. The independent association of skin involvement with patient-reported outcomes (PROs) and their utility as a clinical prognostic marker remain unknown.… read more here.

Keywords: disease; chronic gvhd; mortality; cutaneous chronic ... See more keywords

Multiomics Analysis Identifies SOCS1 as Restraining T Cell Activation and Preventing Graft‐Versus‐Host Disease

Sign Up to like & get
recommendations!
Published in 2022 at "Advanced Science"

DOI: 10.1002/advs.202200978

Abstract: Graft‐versus‐host disease (GVHD) is a major life‐threatening complication of allogeneic hematopoietic stem cell transplantation (allo‐HSCT). Inflammatory signaling pathways promote T‐cell activation and are involved in the pathogenesis of GVHD. Suppressor of cytokine signaling 1 (SOCS1)… read more here.

Keywords: gvhd; cell activation; analysis; graft versus ... See more keywords
Photo by mischievous_penguins from unsplash

The association of histologic grade with acute graft‐versus‐host disease response and outcomes

Sign Up to like & get
recommendations!
Published in 2017 at "American Journal of Hematology"

DOI: 10.1002/ajh.24749

Abstract: Consensus criteria are routinely used to clinically grade acute graft‐versus‐host disease (GVHD). A histologic grading system for acute GVHD is available, but there are limited data on its correlation with clinical grade and hematopoietic cell… read more here.

Keywords: histologic; response; grade; clinical grade ... See more keywords

Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry.

Sign Up to like & get
recommendations!
Published in 2017 at "American journal of hematology"

DOI: 10.1002/ajh.24857

Abstract: other day for 6 doses. This was followed by a maintenance dose of 120 mg/kg IV weekly for seven weeks in responding patients. Four patients received AAT as the first therapy option after demonstrating steroid-refractory… read more here.

Keywords: therapy; multiple myeloma; steroid refractory; gvhd ... See more keywords

A population‐based study of outcomes in polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the United States from 2001 to 2015: Comparison with data from a Mayo Clinic single institutional series

Sign Up to like & get
recommendations!
Published in 2021 at "American Journal of Hematology"

DOI: 10.1002/ajh.26377

Abstract: REFERENCES 1. Westin JR, Saliba RM, De Lima M, et al. Steroid-refractory acute GVHD: predictors and outcomes. Adv Hematol. 2011;2011:601953-601958. 2. MacMillan ML, DeFor TE, Weisdorf DJ. What predicts high risk acute graft-versus-host disease (GVHD)… read more here.

Keywords: gvhd; acute; study; host disease ... See more keywords

Risk Factors for and Impact of Pre‐Engraftment Syndrome on Outcomes Following Single‐Unit Cord Blood Transplantation in Adults

Sign Up to like & get
recommendations!
Published in 2025 at "American Journal of Hematology"

DOI: 10.1002/ajh.70094

Abstract: Pre‐engraftment syndrome (PES) is a unique complication of cord blood transplantation (CBT) whose risk factors and impact on transplant outcomes remain controversial. Using a nationwide database in Japan, we analyzed a total of 3734 patients… read more here.

Keywords: pre engraftment; engraftment syndrome; gvhd; risk factors ... See more keywords

Long-term follow-up of a single institution pilot study of sirolimus, tacrolimus, and short course methotrexate for graft versus host disease prophylaxis in mismatched unrelated donor allogeneic stem cell transplantation

Sign Up to like & get
recommendations!
Published in 2018 at "Annals of Hematology"

DOI: 10.1007/s00277-018-3427-1

Abstract: Dear Editor, Allogeneic stem cell transplantation (allo-SCT) is a potentially curative treatment for patients with hematologic malignancies [1]. However, overall survival (OS) is often compromised by treatment-related complications such as graftversus-host disease (GVHD). Recipients of… read more here.

Keywords: sirolimus tacrolimus; acute gvhd; methotrexate; study ... See more keywords

Reduced risk of chronic GVHD by low-dose rATG in adult matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies

Sign Up to like & get
recommendations!
Published in 2019 at "Annals of Hematology"

DOI: 10.1007/s00277-019-03884-8

Abstract: The optimal rabbit anti-thymocyte globulin (rATG) graft-versus-host disease (GVHD) prophylaxis regimen in matched sibling donor peripheral blood stem cell transplantation (MSD-PBSCT) remains to be elucidated. In this prospective study, we used low-dose rATG for GVHD… read more here.

Keywords: ratg; transplantation; sibling donor; gvhd ... See more keywords

Comparative longitudinal analysis of pulmonary function post-pediatric Allo-HSCT: benign vs. malignant diseases and early predictors

Sign Up to like & get
recommendations!
Published in 2025 at "Annals of Hematology"

DOI: 10.1007/s00277-025-06537-1

Abstract: Pulmonary complications are a major cause of morbidity following pediatric allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, longitudinal pulmonary function test (PFT) trajectories and early predictors of dysfunction, particularly the interplay between underlying disease, PFTs,… read more here.

Keywords: pulmonary function; allo hsct; post; early predictors ... See more keywords

Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan

Sign Up to like & get
recommendations!
Published in 2019 at "International Journal of Hematology"

DOI: 10.1007/s12185-019-02601-5

Abstract: We investigated the safety and efficacy of mycophenolate mofetil (MMF) in the prevention and treatment of graft-versus-host disease (GVHD) using a nationwide retrospective survey in Japanese children undergoing hematopoietic stem cell transplantation (HSCT). Overall, 141… read more here.

Keywords: treatment; versus host; prophylaxis; gvhd ... See more keywords

A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation

Sign Up to like & get
recommendations!
Published in 2019 at "International Journal of Hematology"

DOI: 10.1007/s12185-019-02702-1

Abstract: Graft-versus-host disease (GVHD) is a serious complication of allogeneic stem cell transplantation (SCT). Here, we report a rare case of GVHD involving the central nervous system (CNS). A 35-year-old woman was diagnosed with myelodysplastic syndrome… read more here.

Keywords: disease; cns; case; transplantation ... See more keywords